Intuitive Surgical Inc banner

Intuitive Surgical Inc
F:IUI1

Watchlist Manager
Intuitive Surgical Inc Logo
Intuitive Surgical Inc
F:IUI1
Watchlist
Price: 370.15 EUR 6.93% Market Closed
Market Cap: €131.5B

Wall St Price Targets

IUI1 Price Targets Summary
Intuitive Surgical Inc

Wall Street analysts forecast IUI1 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IUI1 is 509.94 EUR with a low forecast of 323.7 EUR and a high forecast of 689.6 EUR.

Lowest Forecast
Price Target
323.7 EUR
13% Downside
Average Forecast
Price Target
509.94 EUR
38% Upside
Highest Forecast
Price Target
689.6 EUR
86% Upside
Intuitive Surgical Inc Competitors:
Price Targets
9688
Zai Lab Ltd
45% Upside
CAMT
Camtek Ltd
35% Upside

Revenue
Forecast

13% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
13% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 8 years is 11%.

Gross Profit
Forecast

13% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
13% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 14 years, the compound annual growth rate for Gross Profit has been 13%. The projected CAGR for the next 8 years is 12%.

Operating Income
Forecast

11% / Year
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-21%
Average Miss
11% / Year
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-21%
Average Miss

Over the last 14 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 5 years is 21%.

Pre-Tax Income
Forecast

12% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-18%
Average Miss
12% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-18%
Average Miss

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 24%.

Net Income
Forecast

13% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss
13% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Over the last 14 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 8 years is 13%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is IUI1's stock price target?
Price Target
509.94 EUR

According to Wall Street analysts, the average 1-year price target for IUI1 is 509.94 EUR with a low forecast of 323.7 EUR and a high forecast of 689.6 EUR.

What is the Revenue forecast for Intuitive Surgical Inc?
Projected CAGR
11%

Over the last 14 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 8 years is 11%.

What is the Gross Profit forecast for Intuitive Surgical Inc?
Projected CAGR
12%

Over the last 14 years, the compound annual growth rate for Gross Profit has been 13%. The projected CAGR for the next 8 years is 12%.

What is the Operating Income forecast for Intuitive Surgical Inc?
Projected CAGR
21%

Over the last 14 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 5 years is 21%.

What is the Pre-Tax Income forecast for Intuitive Surgical Inc?
Projected CAGR
24%

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 24%.

What is the Net Income forecast for Intuitive Surgical Inc?
Projected CAGR
13%

Over the last 14 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 8 years is 13%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett